companydata.dkcompanydata.dk

PHARMAZAN PHARMACEUTICALS ApS: Financial statements 2020

CVR: 32478697

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

PHARMAZAN PHARMACEUTICALS ApS (CVR 32478697) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 144,108 and a net result of DKK 111,279 compared with DKK 433,812 the year before. That is a decrease of 68.4% compared with the year before. Equity in the 2020 report amounted to DKK 329,637. The solvency ratio was 76.4%.

Gross Profit
DKK 144,108
Profit/Loss
DKK 111,279
Equity
DKK 329,637
Total Assets
DKK 431,381

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-144 t.111 t.330 t.-
2019-455 t.434 t.567 t.-
2018-211 t.211 t.133 t.-
2017-494 t.494 t.-78 t.-
2016-355 t.355 t.-572 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMAZAN PHARMACEUTICALS ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

PHARMAZAN PHARMACEUTICALS ApS: The 2019 annual report is outMar 12, 2020

PHARMAZAN PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 455,385, and the net result was DKK 433,812.

About PHARMAZAN PHARMACEUTICALS ApS

PHARMAZAN PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Otto Tram. The company is owned by HELSEFARMA ApS and TRAM HOLDING ApS. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -21,837 and a net result of DKK -21,837 compared with DKK -40,416 the year before. Equity in the 2025 report amounted to DKK -64,051.

Source: annual report 2025, Danish Business Authority